Ai Shimizu - Publications

Imported cystic echinococcosis caused by Echinococcus granulosus sensu stricto genotype G3 in Japan.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: March 15, 2026

Diagnostic Potential of Tn-MUC1 in Breast Cancer: A Novel Immunohistochemical Marker Reflecting Tumor Progression.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: August 07, 2025

Primary spinal cord malignant B-cell lymphoma successfully treated with tirabrutinib at relapse: a case report.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: April 16, 2025

Transvitreal endoresection of peripheral exudative hemorrhagic chorioretinopathy: a clinicopathological study.

Journal: BMC ophthalmology

Published: June 16, 2024

Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists' Visual Estimates.

Journal: Diagnostics (Basel, Switzerland)

Published: April 18, 2024

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue With Spontaneous Shrinkage in a Patient With Sjögren Syndrome.

Journal: The Journal of rheumatology

Published: October 01, 2023

The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition.

Journal: Breast cancer (Tokyo, Japan)

Published: September 25, 2023

Helicobacter pylori eradication treatment for primary gastric diffuse large B-cell lymphoma: A single-center analysis.

Journal: World journal of clinical cases

Published: June 23, 2023

Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: May 23, 2023

A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation.

Journal: International journal of hematology

Published: May 13, 2023

Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.

Journal: Breast cancer (Tokyo, Japan)

Published: April 27, 2023

A case of breast angiosarcoma clearly delineated by contrast-enhanced ultrasonography.

Journal: Journal of clinical ultrasound : JCU

Published: February 22, 2023